[ATX] YoY Annual Result on 31-Mar-2015 [#FY]

Stock
[ATX] Amplia Therapeutics Limited
Announcement Date
30-Mar-2015
Financial Year
2015
Quarter
31-Mar-2015 [#FY]
Profit Trend
YoY- -16.51%
Quarter Report
ATX's Result
ATX's Financial Summary
View:
Show?
Annual Result
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 30/06/13 31/03/12 CAGR
Revenue 580 1,798 2,263 30 0 0 0 -
PBT -4,298 -8,874 -7,206 -5,237 -4,495 -3,388 -3,254 4.74%
Tax -0 -1,798 -2,263 -162 521 0 0 -
NP -4,298 -7,076 -4,943 -5,237 -4,495 -3,388 -3,254 4.74%
Tax Rate - - - - - - - -
Total Cost 4,878 8,874 7,206 5,267 4,495 3,388 3,254 6.97%
Ratio Analysis
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 30/06/13 31/03/12 CAGR
NP Margin -740.59 -393.54 -218.40 -17,278.70 0.00 0.00 0.00 -
Per Share
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 30/06/13 31/03/12 CAGR
EPS -0.17 -0.30 -0.24 -0.27 -0.34 -0.20 -0.15 2.10%
EPS Diluted -0.17 -0.30 -0.24 -0.27 -0.34 -0.20 -0.15 2.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.